ValueAct Capital Raises Stake in MDS Inc. (MDZ) to 8.7%

In an amended 13D filing after the close Monday on MDS Inc. (NYSE: MDZ), ValueAct Capital disclosed an 8.7% stake (12.5 million shares) in the Company. This is up from the 7.7% (11 million share) stake the firm disclosed in a past filing.

From the Purpose of Transaction section of the filing (unchanged from past filing):

... "In pursuing such investment purposes, the Reporting Persons may further purchase, hold, vote, trade, dispose or otherwise deal in the Common Stock at times, and in such manner, as they deem advisable to benefit from changes in market prices of such Common Stock, changes in the Issuer's operations, business strategy or prospects, or from sale or merger of the Issuer. To evaluate such alternatives, the Reporting Persons will routinely monitor the Issuer's operations, prospects, business development, management, competitive and strategic matters, capital structure, and prevailing market conditions, as well as alternative investment opportunities, liquidity requirements of the Reporting Persons and other investment considerations. Consistent with its investment research methods and evaluation criteria, the Reporting Persons may discuss such matters with management or directors of the Issuer, other shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other investors. ..."